-
My Account
In App
My Account
BSE Live
Sep 05, 15:38Prev. Close
3.93
Open Price
3.70
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Sep 10, 15:31Prev. Close
3.65
Open Price
3.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Ankur Drugs & Pharma (in Rs. Cr.) | Mar 07 | Mar 06 | Mar 05 | Mar 04 | |
| Per Share Ratios | |||||
| Basic EPS (Rs.) | 26.04 | 14.72 | 5.23 | 3.26 | |
| Diluted EPS (Rs.) | 26.04 | 14.72 | 5.23 | 3.26 | |
| Cash EPS (Rs.) | 28.48 | 17.41 | 7.42 | 4.42 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 68.63 | 30.33 | 17.33 | 13.31 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 68.63 | 30.33 | 17.33 | 13.31 | |
| Dividend / Share(Rs.) | 2.00 | 1.50 | 1.00 | 1.00 | |
| Revenue from Operations/Share (Rs.) | 261.91 | 143.64 | 82.75 | 57.82 | |
| PBDIT/Share (Rs.) | 38.68 | 23.00 | 13.44 | 10.72 | |
| PBIT/Share (Rs.) | 36.29 | 20.37 | 11.31 | 9.63 | |
| PBT/Share (Rs.) | 28.85 | 16.26 | 7.66 | 7.68 | |
| Net Profit/Share (Rs.) | 26.04 | 14.72 | 5.23 | 3.26 | |
| Profitability Ratios | |||||
| PBDIT Margin (%) | 14.76 | 16.00 | 16.24 | 18.54 | |
| PBIT Margin (%) | 13.85 | 14.17 | 13.67 | 16.64 | |
| PBT Margin (%) | 11.01 | 11.32 | 9.26 | 13.28 | |
| Net Profit Margin (%) | 9.94 | 10.24 | 6.31 | 5.63 | |
| Return on Networth / Equity (%) | 37.93 | 48.51 | 30.17 | 24.48 | |
| Return on Capital Employed (%) | 9.99 | 11.79 | 9.49 | 8.92 | |
| Return on Assets (%) | 7.21 | 8.93 | 6.68 | 6.35 | |
| Total Debt/Equity (X) | 3.83 | 3.86 | 2.90 | 2.12 | |
| Asset Turnover Ratio (%) | 72.61 | 87.21 | 105.76 | 112.74 | |
| Liquidity Ratios | |||||
| Current Ratio (X) | 1.22 | 1.52 | 1.46 | 1.47 | |
| Quick Ratio (X) | 0.77 | 0.87 | 0.81 | 0.67 | |
| Inventory Turnover Ratio (X) | 5.81 | 5.56 | 5.43 | 4.95 | |
| Dividend Payout Ratio (NP) (%) | 6.92 | 10.19 | 19.12 | 30.69 | |
| Dividend Payout Ratio (CP) (%) | 6.32 | 8.61 | 13.47 | 22.63 | |
| Earnings Retention Ratio (%) | 93.08 | 89.81 | 80.88 | 69.31 | |
| Cash Earnings Retention Ratio (%) | 93.68 | 91.39 | 86.53 | 77.37 | |
| Valuation Ratios | |||||
| Enterprise Value (Cr.) | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 93.07 | 89.80 | 80.87 | 69.30 | |
| Price/BV (X) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 | 0.00 |
